Sep 28
Doctors selling dubious stem cell treatments isn’t just a problem in the U.S., suggests a new study published in Regenerative Medicine. Clinics in Canada are also marketing these treatments directly to consumers, the study found, and seemingly misleading them about their benefits and risks.
Post a Comment